Literature DB >> 8846784

Identification of novel phosphorylation sites required for activation of MAPKAP kinase-2.

R Ben-Levy1, I A Leighton, Y N Doza, P Attwood, N Morrice, C J Marshall, P Cohen.   

Abstract

MAP kinase-activated protein (MAPKAP) kinase-2 is activated in vivo by reactivating kinase (RK), a MAP kinase (MAPK) homologue stimulated by cytokines and cellular stresses. Here we show that in vitro RK phosphorylates human GST-MAPKAP kinase-2 at Thr25 in the proline-rich N-terminal region Thr222 and Ser272 in the catalytic domain and Thr334 in the C-terminal domain. Using novel methodology we demonstrate that activation of MAPKAP kinase-2 requires the phosphorylation of any two of the three residues Thr222, Ser272 and Thr334. Ser9, Thr25, Thr222, Ser272, Thr334 and Thr338 became 32P-labelled in stressed KB cells and labelling was prevented by the specific RK inhibitor SB 203580, establishing that RK phosphorylates Thr25, Thr222, Ser272 and Thr334 in vivo. The 32P-labelling of Thr338 is likely to result from autophosphorylation. GST-MAPKAP kinase-2 lacking the N-terminal domain was inactive, but activated fully when phosphorylated at Thr222, Ser272 and Thr334 by p42 MAPK or RK. In contrast, full-length GST-MAPKAP kinase-2 was phosphorylated at Thr25 (and not activated) by p42 MAPK, suggesting a role for the N-terminal domain in specifying activation by RK in vivo. The mutant Asp222/Asp334 was 20% as active as phosphorylated MAPKAP kinase-2, and this constitutively active form may be useful for studying its physiological roles.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8846784      PMCID: PMC394711          DOI: 10.1002/j.1460-2075.1995.tb00280.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  21 in total

1.  Activation of the MAP kinase pathway by the protein kinase raf.

Authors:  L R Howe; S J Leevers; N Gómez; S Nakielny; P Cohen; C J Marshall
Journal:  Cell       Date:  1992-10-16       Impact factor: 41.582

2.  An investigation of the substrate specificity of protein phosphatase 2C using synthetic peptide substrates; comparison with protein phosphatase 2A.

Authors:  A Donella Deana; C H Mac Gowan; P Cohen; F Marchiori; H E Meyer; L A Pinna
Journal:  Biochim Biophys Acta       Date:  1990-02-19

3.  Protein phosphatase-1 and protein phosphatase-2A from rabbit skeletal muscle.

Authors:  P Cohen; S Alemany; B A Hemmings; T J Resink; P Strålfors; H Y Tung
Journal:  Methods Enzymol       Date:  1988       Impact factor: 1.600

4.  Induction of four proteins in chick embryo cells by sodium arsenite.

Authors:  D Johnston; H Oppermann; J Jackson; W Levinson
Journal:  J Biol Chem       Date:  1980-07-25       Impact factor: 5.157

5.  SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1.

Authors:  A Cuenda; J Rouse; Y N Doza; R Meier; P Cohen; T F Gallagher; P R Young; J C Lee
Journal:  FEBS Lett       Date:  1995-05-08       Impact factor: 4.124

6.  Identification of MAPKAP kinase 2 as a major enzyme responsible for the phosphorylation of the small mammalian heat shock proteins.

Authors:  D Stokoe; K Engel; D G Campbell; P Cohen; M Gaestel
Journal:  FEBS Lett       Date:  1992-11-30       Impact factor: 4.124

7.  Identification of insulin-stimulated protein kinase-1 as the rabbit equivalent of rskmo-2. Identification of two threonines phosphorylated during activation by mitogen-activated protein kinase.

Authors:  C Sutherland; D G Campbell; P Cohen
Journal:  Eur J Biochem       Date:  1993-03-01

8.  The MAP kinase-activated protein kinase 2 contains a proline-rich SH3-binding domain.

Authors:  K Engel; K Plath; M Gaestel
Journal:  FEBS Lett       Date:  1993-12-20       Impact factor: 4.124

9.  Isolation of monoclonal antibodies specific for human c-myc proto-oncogene product.

Authors:  G I Evan; G K Lewis; G Ramsay; J M Bishop
Journal:  Mol Cell Biol       Date:  1985-12       Impact factor: 4.272

10.  MAPKAP kinase-2; a novel protein kinase activated by mitogen-activated protein kinase.

Authors:  D Stokoe; D G Campbell; S Nakielny; H Hidaka; S J Leevers; C Marshall; P Cohen
Journal:  EMBO J       Date:  1992-11       Impact factor: 11.598

View more
  65 in total

1.  Quantitative phosphoproteomic analysis of IL-33-mediated signaling.

Authors:  Sneha M Pinto; Raja Sekhar Nirujogi; Pamela Leal Rojas; Arun H Patil; Srikanth S Manda; Yashwanth Subbannayya; Juan Carlos Roa; Aditi Chatterjee; T S Keshava Prasad; Akhilesh Pandey
Journal:  Proteomics       Date:  2015-01       Impact factor: 3.984

Review 2.  ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions.

Authors:  Philippe P Roux; John Blenis
Journal:  Microbiol Mol Biol Rev       Date:  2004-06       Impact factor: 11.056

3.  Identifying protein construct variants with increased crystallization propensity--a case study.

Authors:  Guido A Malawski; Roman C Hillig; Felipe Monteclaro; Uwe Eberspaecher; Arndt A P Schmitz; Kerstin Crusius; Martina Huber; Ursula Egner; Peter Donner; Beate Müller-Tiemann
Journal:  Protein Sci       Date:  2006-12       Impact factor: 6.725

4.  p53-deficient cells rely on ATM- and ATR-mediated checkpoint signaling through the p38MAPK/MK2 pathway for survival after DNA damage.

Authors:  H Christian Reinhardt; Aaron S Aslanian; Jacqueline A Lees; Michael B Yaffe
Journal:  Cancer Cell       Date:  2007-02       Impact factor: 31.743

5.  Regulation of cyclooxygenase 2 mRNA stability by the mitogen-activated protein kinase p38 signaling cascade.

Authors:  M Lasa; K R Mahtani; A Finch; G Brewer; J Saklatvala; A R Clark
Journal:  Mol Cell Biol       Date:  2000-06       Impact factor: 4.272

6.  Both binding and activation of p38 mitogen-activated protein kinase (MAPK) play essential roles in regulation of the nucleocytoplasmic distribution of MAPK-activated protein kinase 5 by cellular stress.

Authors:  Ole Morten Seternes; Bjarne Johansen; Beate Hegge; Mona Johannessen; Stephen M Keyse; Ugo Moens
Journal:  Mol Cell Biol       Date:  2002-10       Impact factor: 4.272

7.  MAPKAP kinase 3 suppresses Ifng gene expression and attenuates NK cell cytotoxicity and Th1 CD4 T-cell development upon influenza A virus infection.

Authors:  Katharina Köther; Carolin Nordhoff; Dörthe Masemann; Georg Varga; Jay H Bream; Matthias Gaestel; Viktor Wixler; Stephan Ludwig
Journal:  FASEB J       Date:  2014-06-16       Impact factor: 5.191

8.  PRAK, a novel protein kinase regulated by the p38 MAP kinase.

Authors:  L New; Y Jiang; M Zhao; K Liu; W Zhu; L J Flood; Y Kato; G C Parry; J Han
Journal:  EMBO J       Date:  1998-06-15       Impact factor: 11.598

9.  Leptomycin B-sensitive nuclear export of MAPKAP kinase 2 is regulated by phosphorylation.

Authors:  K Engel; A Kotlyarov; M Gaestel
Journal:  EMBO J       Date:  1998-06-15       Impact factor: 11.598

10.  MAPK-activated protein kinase 2 is required for mouse meiotic spindle assembly and kinetochore-microtubule attachment.

Authors:  Ju Yuan; Bao-Zeng Xu; Shu-Tao Qi; Jing-Shan Tong; Liang Wei; Mo Li; Ying-Chun Ouyang; Yi Hou; Heide Schatten; Qing-Yuan Sun
Journal:  PLoS One       Date:  2010-06-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.